Exploring the performances of five healthcare stocks-CNC, VRTX, SGEN, MRK, MOH
The SHPH stock have caught eyes of the investors with a surge of over 175 per cent in the morning trading on Thursday.
Bright Green (BGXX) stock soared more than 36 per cent in the pre-market hours on Thursday, drawing attention from the investors.
The AERI has gained attention from several investors after its price soared over 35 per cent on Tuesday morning.
The Akili Inc. (AKLI) stock have caught eyes of the investors on Monday, with a surge of over 100 per cent in morning trading.
The SGFY stock soared over 37 per cent in the pre-market trading session on Monday, after reports showed that Amazon is going to bid for the home heal...
Exploring the performances of four biotech stocks-QURE, BEAM, BLU, ITOS
The AXSM stock caught the eyes of the investors in the pre-market trading session on Friday, as seen by the surge of over 35 per cent in its price.
Exploring performances of 5 hearing aid stocks-EAR, KN, SPB, ENR, DOV
Amid volatile market conditions, healthcare stocks can be a viable option to balance out portfolios.
AbbVie Inc (ABBV) and AstraZeneca PLC (AZN) have reported their second quarter earnings on Friday.
With healthcare companies like Pfizer, Inc. (NYSE: PFE) and Merck & Co. Inc. (NYSE: MRK) releasing their latest quarterly reports this week, the marke...
Two pharma stocks to explore as moneypox disease is spreading across the world.
Stocks of Revelation Biosciences, Inc. (NASDAQ: REVB) and GeoVax Labs, Inc. (NASDAQ: GOVX) have been creating a buzz on the stock markets on Monday, J...
The US healthcare sector has gained significant attention recently, with a notable number of investors exploring health stocks amid rising monkeypox c...
Abbott Laboratories (ABT) sales rose 10.1% YoY, company raises EPS guidance.
Highlights:,Malvern, Pennsylvania-based Neuronetics Inc is focused on developing products to treat patients with psychiatric disorders.,Today, it anno...
Bioscience Inc. (Nasdaq: VIVO) concedes to US$1.5 Bn buyout deal by Seoul-based device maker SD Biosensor Inc. for US$1.53 billion.
Healthcare sector has been in good stead and shown resilience in a bearish market.
NeuroSense stock soared over 35% on Thursday after study results showing potential of its drug combination for Alzheimer's treatment.